Bharglob 16.5% Injection
11,76$
10,76$
Bharglob 16.5% Injection is a specialized immunosuppressive medication designed to address immunoglobulin deficiencies, whether they are congenital or acquired. This injection is particularly beneficial for patients suffering from primary immunodeficiency, which is present from birth, as well as secondary immunodeficiency that develops later in life. In addition to supporting those with low immunoglobulin levels, Bharglob is effectively utilized in managing various inflammatory conditions, including primary immune thrombocytopenia, Guillain-Barre syndrome, Kawasaki disease, chronic inflammatory demyelinating polyneuropathy (CIDP), and multifocal motor neuropathy. By modulating the immune response, this treatment aids in reducing inflammation and restoring balance in the immune system. It is important for patients to be aware of potential side effects, including increased susceptibility to infections due to its immunosuppressive nature. Prior to administration, a healthcare professional should evaluate the patient's medical history and any concurrent medications to ensure safety. With its targeted approach, Bharglob 16.5% Injection plays a crucial role in improving the quality of life for individuals facing these challenging health conditions.
Quantité
Active Pharmaceutical Ingredient
Uses
• Bharglob 165 injection is commonly used in the management of Guillain-Barré Syndrome, a condition characterized by rapid onset muscle weakness. This injection helps modulate the immune response, providing essential support during recovery. Patients receiving Bharglob 165 injection may experience improved mobility and reduced symptoms associated with this disorder. It is a vital part of the treatment regimen for those affected.
• In cases of dermatomyositis, Bharglob 165 injection serves to enhance the immune system's functionality. This autoimmune disease leads to muscle weakness and skin rashes, and the injection aids in reducing inflammation and promoting muscle strength. By utilizing Bharglob 165 injection, healthcare providers can better manage symptoms and improve the overall quality of life for patients. Regular administration can help stabilize the condition over time.
• Bharglob 165 injection is also indicated for patients suffering from immune thrombocytopenia, a disorder that results in low platelet counts. The injection helps in increasing platelet levels, thereby reducing the risk of bleeding complications. By incorporating Bharglob 165 injection into treatment plans, clinicians can effectively address the underlying immune dysfunction. This contributes to better health outcomes for individuals living with this condition.
• For individuals undergoing organ transplantation, Bharglob 165 injection plays a crucial role in preventing rejection. It assists in modulating the immune response, which is essential for the success of the transplant. By using Bharglob 165 injection, medical teams can enhance the body's acceptance of the new organ. This is particularly important in the early stages post-transplant, ensuring better integration and function of the transplanted organ.
Benefits
Bharglob 16.5% Injection works by replacing the missing antibodies needed to fight infection and inflammation. It works in the same way as the body's own immunoglobulins. Immunoglobulins are a vital part of the immune system, responsible for recognising antigens or foreign substances in the body and facilitating their elimination. Human Normal Immunoglobulin 16.5% Injection is used to treat immunoglobulin deficiency in people with primary immunodeficiency (present from birth) and secondary immunodeficiency (developed later in life). It is also used to treat inflammatory disorders such as primary immune thrombocytopenia (low platelet count), Guillain-Barre syndrome (temporary inflammation of the peripheral nerves causing weakness in the legs and upper limbs), Kawasaki disease (inflammation of the blood vessels in children), chronic inflammatory demyelinating polyneuropathy or CIDP (long-term inflammation of the peripheral nerves) and multifocal motor neuropathy (progressive disease causing weakness in the arms and legs.
Side Effects
As with all medicines, Bharglob 16.5% Vial may have side effects which do not require medical attention and which will disappear as your body adjusts to the medicine. Tell your doctor if they persist or if you're worried about them.
Most Common Side Effects
• Muscle cramps
• Joint pain
• Back pain
• Flushing
• Chills
• Nausea
• Vomiting
• Sensitivity to light
Common Side Effects
• Shortness of Breath
• Hypertension
• Fainting
• Irregular Heartbeats
• Extreme tiredness
• High Fever
• Anaphylaxis if allergic to IVIg.
• Brain Infection
• Lung problems
• Dizziness
• Sore throat
• Dark Urine
• Yellow Eyes and Skin
• Eye pain
How To Use
Human Normal Immunoglobulin 16.5% Injection should only be administered by a qualified healthcare professional. It is important to avoid self-administration. The injection is given subcutaneously, which means it is injected under the skin. The infusion is given intravenously, which means it is given directly into a vein.
Safety Advice
• Alcohol: There is no evidence of an interaction between alcohol and Bharglob 16.5%. However, it is advisable to moderate or avoid alcohol consumption to minimise the risk of adverse reactions.
• Kidney: Patients with kidney disease should use Human Normal Immunoglobulin 16.5% Injection with caution. If deemed necessary, your doctor may adjust the dosage according to your specific condition.
• Breastfeeding: Before starting treatment with Bharglob Injection it is important to tell your doctor if you are currently breastfeeding. Your doctor will consider the potential benefits and risks of this medicine before making any recommendations.
• Liver: Patients with liver disease should use Bharglob 16.5% with caution. If deemed necessary, your doctor may adjust the dosage according to your specific condition.
• Pregnancy: Before starting treatment with Bharglob 16.5% Vial it is essential to tell your doctor if you are pregnant or planning to become pregnant. Your doctor will consider the potential benefits and risks before prescribing this medicine.
• Driving: Bharglob 16.5% Injection may cause dizziness. Do not drive or use heavy machinery if you feel dizzy after receiving this medicine.